Publications

Read our latest publications

Filter by:

Solution

Carcinogenicity assessment

Data sharing

Impurity and degradant control

In silico mutagenicity assessment

Metabolite identification and analysis

Nitrosamine impurity risk assessment

Safety profiling in drug discovery

Skin sensitisation assessment

Toxicity assessment of impurities

Publication Type

Date

Poster

Why do some mutagenic N-nitrosamines not require metabolic activation?

Nov 2023
Data sharing, Nitrosamine impurity risk assessment

Paper

Use of the TD50 99 % CI for single dose rodent carcinogenicity studies

Nov 2023
Carcinogenicity assessment

QMRF

Derek Nexus version 6.3 Carcinogenicity QMRF

Nov 2023
Carcinogenicity assessment

QMRF

Derek Nexus version 6.3 Teratogenicity QMRF

Nov 2023

QMRF

Derek Nexus version 6.3 Mutagenicity QMRF

Nov 2023
In silico mutagenicity assessment

QMRF

Derek Nexus version 6.3 HERG QMRF

Nov 2023

QMRF

Sarah Nexus version 3.3 Mutagenicity QMRF

Nov 2023
In silico mutagenicity assessment

QMRF

Derek Nexus version 6.3 Chromosome damage QMRF

Nov 2023

QMRF

Derek Nexus version 6.3 Skin sensitisation QMRF

Nov 2023
Skin sensitisation assessment

Paper

Enhancing developmental and reproductive toxicity knowledge: A new AOP stemming from glutathione depletion

Oct 2023
Safety profiling in drug discovery

Paper

Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damage

Oct 2023
Nitrosamine impurity risk assessment

Paper

Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals

Oct 2023
Nitrosamine impurity risk assessment

Filter by:

Solution
- Carcinogenicity assessment
- Data sharing
- Impurity and degradant control
- In silico mutagenicity assessment
- Metabolite identification and analysis
- Nitrosamine impurity risk assessment
- Safety profiling in drug discovery
- Skin sensitisation assessment
- Toxicity assessment of impurities
Publication Type
Date